Isolated codon sequence
AssigneeCB Therapeutics, Inc.
InventorsSher Ali Butt, Jacob Michael Vogan
Life of this patent
Estimating the term…
Loading patent…
AssigneeCB Therapeutics, Inc.
InventorsSher Ali Butt, Jacob Michael Vogan
Estimating the term…
The present invention is a method for the biosynthesis of hundreds of compounds, mainly found in the cannabis plant. The starting material for these compounds can be any biological compound that is used/produced in a biological organism from the sugar family starting materials or other low cost raw materials processed via enzymes or within organisms to give final products. These final products include, but are not limited to: cannabinoids, terpenoids, stilbenoids, flavonoids, phenolic amides, lignanamides, spermidine alkaloids, and phenylpropanoids. Specifically, the present invention relates to the regular, modified, or synthetic gene(s) of select enzymes that are processed and inserted into an expression system (for example, a vector, cosmid, BAC, YAC, phage) to produce modified hosts. The modified host is then optimized for efficient production and yield via manipulation, silencing, and amplifying inserted or other genes in the host, leading to an efficient system for product.
An isolated nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to the nucleotides 5052 to 6671 of SEQ ID NO:
A host organism that comprises an isolated nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to the nucleotides 5052 to 6671 of SEQ ID NO:
Dependencies are inferred from the claim text.